A US study found that mRNA vaccines “dramatically increase” inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for post-vaccination incidents of increased thrombosis, cardiomyopathy, and other vascular events, writes MedicalBrief. The study was published with an expression of concern in the American Heart Association‘s journal, Circulation.
The study was presented by cardiologist Dr Steven Gundry at the Scientific Sessions of the American Heart Association annual conference on 8 November 2021, and published in the AHA’s Circulation. Gundry’s is a controversial figure. Earlier claims, in the book The Plant Paradox, on plant-based diets causing inflammation, have been criticised by some as “pseudoscience”.
The researchers found that the mRNA vaccines dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events after vaccination.
This is not the only study to have found this result, according to the news site, Opindia. It reports that British cardiologist Dr Aseem Malhotra told GB News that a cardiology researcher from the cardiology department of a “prestigious British institution” contacted him to inform that research done by the department had found similar results but decided not to publish. The researcher told Malhotra that they have found links between the inflammation of coronary arteries and the mRNA vaccines from imaging studies.
Abstract
Mrna COVID vaccines dramatically increase endothelial inflammatory markers and ACS risk as measured by the PULS cardiac test: a warning
Steven Gundry, International Heart & Lung Institute, Palm Springs, California.
Published in AHA Circulation on 14 November 2021
Our group has been using the PLUS Cardiac Test (GD Biosciences, Irvine, CA) a clinically validated measurement of multiple protein biomarkers, which generates a score predicting the 5-year risk (percentage chance) of a new Acute Coronary Syndrome (ACS).
The score is based on changes from the norm of multiple protein biomarkers including IL-16, a pro-inflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF), which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.
The score has been measured every three-six months in our patient population for eight years.
Recently, with the advent of the mRNA COVID 19 vaccines by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients. This report summarises those results.
A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac.
These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.
We conclude that the mRNA vaccines dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.
See more from MedicalBrief archives:
Healthy boys at greater risk from vaccination than COVID itself — US analysis
CDC investigates 'relatively few' reports of myocarditis from Pfizer vaccination
Pfizer vaccination linked to 3x high risk of myocarditis — Israel study
Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination